期刊文献+

miR-21反义寡核苷酸增强地西他滨体外抗白血病效应

Enhanced anti-leukemic activity of decitabine to leukemia HL-60 cells by anti-miR-21 oligonucleotide
下载PDF
导出
摘要 目的:研究miR-21反义寡核苷酸(anti-miR-21 oligonucleotide,AMO)对地西他滨(decitabine,DCA)抗白血病效应的影响及可能机制。方法:将AMO和无义寡核苷酸(scramble oligonucleotide,SCR)通过脂质体转染导入HL-60细胞,实时荧光定量PCR(real-time PCR)验证转染效率,再分别与DCA 0.5、2.0和4.0μmol/L作用48 h。Real-time PCR分别检测人周期节律蛋白3(h Per3)mRNA表达,Annexin V/PI法检测凋亡,流式细胞术检测CD117和CD11b平均荧光强度(MFI)。结果:AMO转染组miR-21表达(0.35±0.07)低于空白组(0.71±0.07)和SCR转染组(0.66±0.05),差异有统计学意义(P<0.05)。AMO转染组的HL-60细胞DCA的IC50低于空白组和SCR转染组(P<0.01)。同一浓度下,AMO组的早期凋亡率、CD11b的MFI和h Per3 mRNA均高于同一浓度药物作用的空白组和SCR组,CD117 MFI均低于同一浓度药物作用的空白组和SCR组,差异均具有统计学意义(P<0.01)。结论:AMO能显著促进DCA体外抗白血病效应,其机制可能与其协助激活h Per3的表达有关。 AIM:To investigate the role of anti-miR-21 oligonucleotide ( AMO) in the anti-leukemic activity of decitabine (DCA) in vitro.METHODS:AMO and scramble oligonucleotide (SCR) were constructed and transfected into HL-60 cells.The miR-21 expression was analyzed by real-time PCR to identify the transfection efficiency .The cells were treated with DCA at gradient concentrations (0.5, 2.0 and 4.0 μmol/L) for 48 h.The mRNA expression of human period circadian protein 3 (hPer3) was detected by real-time PCR.The early apoptotic rates were determined by flow cy-tometry with Annexin V/PI staining.Mean fluorescence intensities ( MFI) of CD117 and CD11b were also measured by flow cytometry.RESULTS:The miR-21 relative expression level in AMO group was significantly lower than that in blank group and SCR group (P〈0.01).IC50 of DCA in AMO group was significantly lower than that in blank group and SCR group (P〈0.01).With the same concentration of DCA, the early apoptotic rate, the mRNA expression of hPer3 and the MFI of CD11b in AMO group were significantly higher than those in blank group and SCR group (P〈0.01).The MFI of CD117 in AMO group were significantly lower than those in blank group and SCR group ( P〈0.01 ) .CONCLUSION:Activation of hPer3 expression plays an important role in enhanced anti-leukemic activity of decitabine by AMO in vitro.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2015年第1期109-113,共5页 Chinese Journal of Pathophysiology
基金 舟山市科技局科技计划项目(No.2011C12044)
关键词 人周期节律蛋白3 HL-60细胞 微小RNA-21 地西他滨 Human period circadian protein 3 HL-60 ceils MicroRNA-21 Decitabine
  • 相关文献

参考文献13

  • 1Petrovic N, Mandusic V, Dimitrijevid B, et al. Higher miR- 21 expression in invasive breast carcinomas is associated with positive estrogen and progesterone receptor status in patients from Serbia [ J ]. Med Oncol, 2014, 31 (6) : 977.
  • 2颜黎栩,黄马燕,吴秋良,邵建永.miR-21表达异常与乳腺癌临床病理特征及预后的关系[J].中国病理生理杂志,2009,25(4):676-681. 被引量:18
  • 3陈卫群,卢宏达,孔德勇,刘水逸,汤贝贝,孔庆志,卢忠心.弥漫性大B细胞淋巴瘤患者血清和细胞中miR-21的表达及其临床意义[J].中华检验医学杂志,2012,35(5):431-435. 被引量:6
  • 4Ma Y,Xia H, Liu Y, et al. Silencing miR-21 sensitizes non-small cell lung cancer A549 cells to ionizing radiation through Inhibition of PI3K/Akt [ J ]. Biomed Res Int,2014, 2014:617868.
  • 5Yang H, Hoshino K, Sanchez-Gonzalez B, et al. Antileu- kemia activity of the combination of 5-aza-2'-deoxycytidine with valproic acid [ J ]. Leuk Res, 2005,29 (7) : 739 -748.
  • 6Abujamra AL, dos Santos MP, Roesler R, et al. Histone deacetylase inhibitors: a new perspective for the treatment of leukemia[ J]. Leuk Res,2010,34(6) :687-695.
  • 7Gu L, Song G, Chen L, et al. Inhibition of miR-21 induces biological and behavioral alterations in diffuse large B-cell lymphoma [ J ]. Acta Haematol,2013,130 (2) : 87-94.
  • 8Feng Y,Chen X,Gao L. Knockdown of miR-21 as a novel approach for leukemia therapy[ J]. J Formos Med Assoc, 2010,109(9) :621-613.
  • 9Li Y,Zhu X, Gu J, et al. Anti-miR-21 oligonucleotide en- hances chemosensitivity of leukemic HI_60 cells to arabino- sylcytosine by inducing apoptosis [ J ]. Hematology, 2010, 15(4) :215-221.
  • 10Advani AS, Rodriguez C, Jin T, et al. Increased C-kit inten- sity is a poor prognostic factor for progression-free and overall survival in patients with newly diagnosed AML[ J]. Leuk Res,2008,32(6) :913-918.

二级参考文献50

  • 1刘东海,张乐鸣,张顺,毛联钢,冯伟云.乳腺癌患者c-erBb-2基因荧光定量PCR方法的研究[J].中国病理生理杂志,2006,22(2):380-383. 被引量:1
  • 2Ambros V.MicroRNA pathways in flies and worms:growth,death,fat,stress,and timing[J].Cell,2003,113(6):673-676.
  • 3Iorio MV,Ferracin M,Liu CG,et al.MicroRNA gene expression deregulation in human breast cancer[J].Cancer Res,2005,65(16):7065-7070.
  • 4Chan JA,Krichevsky AM,Kosik KS.MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells[J].Cancer Res,2005,65(14):6029-6033.
  • 5Yanaihara N,Caplen N,Bowman E,et al.Unique microRNA molecular profiles in lung cancer diagnosis and prognosis[J].Cancer Cell,2006,9(3):189-198.
  • 6Singletary SE,Allred C,Ashley P,et al.Staging system for breast cancer:revisions for the 6th edition of the AJCC Cancer Staging Manual[J].Surg Clin North Am,2003,83(4):803-819.
  • 7Livak KJ,Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method[J].Methods,2001,25(4):402-408.
  • 8Gramantieri L,Ferracin M,Fornari F,et al.Cyclin G1 is a target of miR-122a,a microRNA frequently down-regulated in human hepatocellular carcinoma[J].Cancer Res,2007,67(13):6092-6099.
  • 9Rhodes A,Jasani B,Anderson E,et al.Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors:a comparative study involving results from laboratories in 21 countries[J].Am J Clin Pathol,2002,118(3):408-417.
  • 10Si ML,Zhu S,Wu H,et al.miR-21-mediated tumor growth[J].Oncogene,2007,26(19):2799-2803.

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部